Home » Topics » Disease categories and therapies » Nephrology

Nephrology
RSS

RemeGen completes phase II study of telitacicept in IgAN

Aug. 12, 2021

Goldfinch Bio initiates dosing in extension study of GFB-887 for patients with FSGS

Aug. 11, 2021

Allena initiates two phase II trials of its engineered urate oxidase, ALLN-346

Aug. 10, 2021

Phase I data with ANG-3070 pave way for phase II study in primary proteinuric kidney diseases

Aug. 3, 2021

CIHR grant supports Arch's evaluation of LSALT in chronic kidney and lung diseases

July 15, 2021

Chinese investigators divulge P2X3 receptor antagonists

July 6, 2021

DiaMedica reports interim phase II data on DM-199 in chronic kidney disease

June 29, 2021

FDA clears IND for clinical evaluation of CLBS-201 for diabetic kidney disease

June 23, 2021

Shijiazhuang Yiling Pharmaceutical identifies HIPK2 inhibitors

June 14, 2021

Iptacopan safely and effectively stabilizes eGFR in patients with C3 glomerulopathy

June 11, 2021

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...